Bethkis and Chest pain - a phase IV clinical study of FDA data

Summary:

Chest pain is reported as a side effect among people who take Bethkis (tobramycin), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Pulmozyme, and have Cystic fibrosis.

The phase IV clinical study analyzes which people have Chest pain when taking Bethkis. It is created by eHealthMe based on reports of 2,409 people who have side effects when taking Bethkis from the FDA, and is updated regularly.

What is Bethkis?

Bethkis has active ingredients of tobramycin. eHealthMe is studying from 2,409 Bethkis users. Check the latest studies of Bethkis.

What is Chest pain?

Chest pain is found to be associated with 3,455 drugs and 4,889 conditions by eHealthMe. Check the latest studies of Chest pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

2,409 people reported to have side effects when taking Bethkis.
Among them, 37 people (1.54%) have Chest pain.

Among these 37 people:

How long have people been on Bethkis when they have Chest pain? *

What is the gender of people who have Chest pain when taking Bethkis? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Chest pain when taking Bethkis? *

What are other drugs people take besides Bethkis? *

What are other side effects people have besides Chest pain? *

Dyspnea (difficult or laboured breathing): 20 people, 54.05%
Cough: 6 people, 16.22%
Productive Cough: 6 people, 16.22%
Pneumonia: 5 people, 13.51%
Nausea (feeling of having an urge to vomit): 4 people, 10.81%
Heart Rate Increased: 3 people, 8.11%
Coughing Up Blood: 3 people, 8.11%
Pain: 3 people, 8.11%
Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 3 people, 8.11%
Gallstones (stone formation by bile component): 2 people, 5.41%

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 24 people, 64.86%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 8.11%
Wheezing (a high-pitched whistling sound made while you breath): 2 people, 5.41%
Respiratory Disorder (respiratory disease): 2 people, 5.41%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 2 people, 5.41%
Pain: 2 people, 5.41%
Hypersensitivity: 2 people, 5.41%
Stress And Anxiety: 2 people, 5.41%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 1 person, 2.70%
Blood Glucose Decreased: 1 person, 2.70%

* Approximation only. Some reports may have incomplete information.

Do you take Bethkis and have Chest pain?

- Check whether Chest pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Bethkis:

Bethkis (2,409 reports)

Chest pain treatments and more:

Chest pain (363,502 reports)

Browse all side effects of Bethkis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Chest pain:

Chest pain (3,455 drugs)

Browse all the conditions that are associated with Chest pain:

Chest pain (4,889 conditions)

Related publications that referenced our studies

Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tobramycin (the active ingredients of Bethkis) and Bethkis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.